Chemicals & Advanced Materials Global On demand · 24-48h

Global DHA Oil from Algae Market Strategic Research Report

Global DHA Oil from Algae Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global DHA Oil from Algae Market
$4612025
15.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: DHA Content: <35%, DHA Content: 35% – 50%, DHA Content: >50%

By Application: Infant Formula, Nutritional Supplements, Food & Beverage, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: DSM-Firmenich, Roquette, Corbion, Huison, Runke, ADM, Mara Renewables, Cabio, Solutex, Kingdomway, Fermentalg, JC Biotech, Keyuan, Bioplus Life Sciences, Fuxing, ATK Biotech, Xinhe Biotech, Progress Biotech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 143 pages
Market size 2025
$461
Million USD
Forecast CAGR
15.5%
2025-2032
Forecast 2032
$1264.1
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global DHA Oil from Algae market size is predicted to grow from US$ 461 million in 2025 to US$ 1,317 million in 2032; it is expected to grow at a CAGR of 15.5% from 2026 to 2032.

In 2025, global DHA Oil from Algae sales reached approximately 8,277.90 Tons with an average global market price of around 56.94 USD per Kg.

DHA Oil from Algae is a high-value Omega-3 nutritional oil produced from DHA-rich microalgae through strain selection, fermentation, cell disruption, oil extraction, refining, deodorization, oxidation-stability control, and, when required, microencapsulation. Compared with traditional fish-oil-derived DHA, algal DHA is sourced directly from primary producers in the marine food chain and does not depend on deep-sea fish resources. It offers stronger traceability, vegan suitability, more controllable odor, lower exposure to heavy metals and marine contaminants, and more stable quality. The product is typically supplied as refined oil, microencapsulated powder, algal biomass powder, or finished dosage forms such as softgels and drops. It is widely used in infant formula, maternal nutrition, children’s brain and vision development products, adult dietary supplements, functional foods, pet nutrition, and aquafeed. As consumers pay increasing attention to brain health, eye health, clean labels, and sustainable nutrition, DHA Oil from Algae has become an important functional ingredient in the global nutrition and wellness industry, combining scientific recognition, regulatory support, and brand premium potential.

DHA Oil from Algae is a premium fermentation-based nutritional ingredient with the combined attributes of bio-manufacturing, food nutrition, and functional lipids. Its profitability is generally higher than that of ordinary vegetable oils, fish oils, and basic food additives. Based on listed-company annual reports and brokerage research, the gross margin of human-nutrition-grade algal DHA oil can be broadly estimated at around 40%–55%. Applications in infant formula, maternal nutrition, and premium dietary supplements usually enjoy higher margins due to long customer qualification cycles, strict quality standards, and relatively stable orders. Pet nutrition and aquafeed are more price-sensitive and typically carry lower margins. The upstream value chain includes algae strains, carbon sources such as glucose, nitrogen sources, fermentation auxiliaries, antioxidants, encapsulation materials, fermenters, and refining equipment. The midstream covers strain preservation, seed expansion, industrial fermentation, harvesting, cell disruption, extraction, refining, deodorization, microencapsulation, and quality testing. Downstream customers include infant formula producers, dietary supplement companies, food and beverage manufacturers, pet food producers, and aquafeed companies. The industry barrier is not simply the ability to produce DHA, but the capability to maintain high-yield stable strains, control fermentation costs at scale, manage oxidation stability, secure regulatory approvals, pass customer qualification, and deliver through a reliable global supply chain.

Market Development Opportunities & Main Driving Factors

DHA Oil from Algae is evolving from a nutrient fortifier for infant formula into a high-value Omega-3 platform ingredient for full-lifecycle health management. Rising consumer awareness of brain health, eye health, maternal nutrition, child development, healthy aging, and cardiovascular wellness is expanding DHA demand from infant formula into dietary supplements, functional foods, medical nutrition, pet nutrition, and aquafeed. At the same time, fish oil faces constraints related to marine resources, contaminant control, odor stability, and sustainable sourcing, encouraging food and nutrition brands to seek more stable, cleaner, and more differentiated alternatives. Algal DHA, produced through controlled industrial fermentation, offers vegan, traceable, and non-fish-source advantages, making it an increasingly important option for global nutrition brands seeking product upgrades and differentiated positioning. In China, the inclusion of DHA algal oil in the health food filing system further strengthens regulatory certainty and improves commercialization efficiency in the domestic market.

Market Challenges, Risks, & Restraints

The key challenges in the DHA Oil from Algae industry lie in cost control, quality stability, and market competition. Microalgae fermentation requires significant equipment investment and strong process-control capabilities. Carbon sources, energy consumption, fermentation efficiency, oil extraction yield, refining losses, and capacity utilization all directly affect unit costs. DHA is a highly unsaturated fatty acid and is highly prone to oxidation, so odor, peroxide value, acid value, color, microencapsulation efficiency, and shelf life must be tightly controlled. For infant formula and premium nutrition customers, supplier qualification cycles are long and quality audits are strict. Any batch inconsistency or flavor instability may directly affect customer partnerships and brand trust. As Chinese capacity expands and international patent barriers weaken, price competition may intensify. Companies that rely only on capacity expansion and low-price orders may face profit volatility. Future competition will shift from production capacity to cost efficiency, quality consistency, regulatory access, customer structure, and application innovation.

Downstream Demand Trends

Future downstream demand for DHA Oil from Algae is expected to show structural growth characterized by stable infant formula demand, adult nutrition expansion, and increasing animal nutrition applications. Infant formula will remain the most important and stable application, while updated standards, formula upgrades, and premiumization will continue to drive brand owners to focus on DHA source, stability, traceability, and regulatory compliance. Adult nutrition offers broader category extension potential. Pregnant women, children and teenagers, older adults, vegetarians, and knowledge workers will support innovation in softgels, drops, powders, gummies, and functional beverages. Pet nutrition and aquafeed will provide new scale-up opportunities. Premium pet food brands are increasingly focusing on coat health, immunity, and cognitive support, while aquafeed producers are using algal DHA for fish-oil replacement and Omega-3 enrichment in seafood products. Overall, DHA Oil from Algae is moving beyond a single nutrition fortifier and becoming a key functional ingredient that connects health value, sustainability value, and premium brand positioning.

Key Questions Addressed in this Report

What is the 10-year outlook for the global DHA Oil from Algae market?

What factors are driving DHA Oil from Algae market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do DHA Oil from Algae market opportunities vary by end market size?

How does DHA Oil from Algae break out by Type, by Application?

This report presents a comprehensive overview of the global DHA Oil from Algae market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • DHA Content: <35%
  • DHA Content: 35% – 50%
  • DHA Content: >50%

Segment by Source

  • Schizochytrium
  • Crypthecodinium Cohnii
  • Others

Segment by Process

  • Traditional Solvent Extraction
  • Enzymatic Extraction
  • Supercritical CO2 Extraction

Segment by Application

  • Infant Formula
  • Nutritional Supplements
  • Food & Beverage
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global DHA Oil from Algae market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Infant Formula, Nutritional Supplements, Food & Beverage evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global DHA Oil from Algae Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 15.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$461
2025
Forecast
$1264.1
2032
CAGR
15.5%
2025–2032
Regiones
5
global
Key companies
DSM-FirmenichRoquetteCorbionHuisonRunkeADMMara RenewablesCabio
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
DHA Content: <35%DHA Content: 35% – 50%DHA Content: >50%
By Application
Infant FormulaNutritional SupplementsFood & BeverageOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 DHA Content: <35%
  • 3.1.3 DHA Content: 35% – 50%
  • 3.1.4 DHA Content: >50%
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Infant Formula
  • 4.1.3 Nutritional Supplements
  • 4.1.4 Food & Beverage
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 DSM-Firmenich
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Roquette
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Corbion
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Huison
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Runke
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 ADM
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Mara Renewables
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Cabio
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Solutex
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Kingdomway
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Fermentalg
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 JC Biotech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Keyuan
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Bioplus Life Sciences
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Fuxing
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 ATK Biotech
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Xinhe Biotech
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Progress Biotech
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global DHA Oil from Algae market?
The global DHA Oil from Algae market is estimated at US$ 461 million in 2025 (base year) and is projected to reach US$ 1.32 billion by 2032.
How fast is the DHA Oil from Algae market expected to grow?
The market is expected to grow at a CAGR of 15.5% from 2026 to 2032, expanding from US$ 461 million in 2025 to US$ 1.32 billion in 2032, roughly 2.9 times its base-year value.
What does the DHA Oil from Algae market cover?
In 2025, global DHA Oil from Algae sales reached approximately 8,277.90 Tons with an average global market price of around 56.94 USD per Kg.
How is the DHA Oil from Algae market segmented by type?
By type, the market is segmented into DHA Content: <35%, DHA Content: 35% – 50% and DHA Content: >50%.
What are the key applications of DHA Oil from Algae?
Key applications covered include Infant Formula, Nutritional Supplements, Food & Beverage and Others.
Which companies are profiled in the DHA Oil from Algae market report?
Key players profiled include DSM-Firmenich, Roquette, Corbion, Huison, Runke, ADM, Mara Renewables and Cabio, among 18 companies covered in total.
What geographies does the DHA Oil from Algae market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for DHA Oil from Algae?
Market Development Opportunities & Main Driving Factors
What are the main risks and barriers in the DHA Oil from Algae market?
The industry barrier is not simply the ability to produce DHA, but the capability to maintain high-yield stable strains, control fermentation costs at scale, manage oxidation stability, secure regulatory approvals, pass customer qualification, and deliver through a reliable global supply chain.
Who should buy the DHA Oil from Algae market report?
The report is intended for manufacturers and solution providers, distributors and end users in Infant Formula, Nutritional Supplements and Food & Beverage, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the DHA Oil from Algae market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.